15:18 , Sep 1, 2017 |  BC Week In Review  |  Financial News

Akeso raises $45M in series B

On Aug. 28, Akeso Biopharma Inc. (Zhongshan, China) raised RMB300 million ($45.2 million) in a series B round led by Shenzhen GTJA Investment Group. Existing investors Shenzhen Capital, Qianhai Parent Fund and Qianhai TRI Wise...
22:13 , Aug 28, 2017 |  BC Extra  |  Financial News

Akeso raises $45M in series B

Akeso Biopharma Inc. (Zhongshan, China) raised RMB300 million ($45.2 million) in a series B round led by Shenzhen GTJA Investment Group. Existing investors Shenzhen Capital, Qianhai Parent Fund and Qianhai TRI Wise Capital participated. In 2015,...
08:00 , Dec 21, 2015 |  BC Week In Review  |  Company News

Akeso, Merck deal

Akeso granted Merck exclusive, worldwide rights to develop and commercialize AK-107. The product is an immune checkpoint blocking antibody in preclinical development to treat cancer. Akeso will receive an undisclosed upfront payment and is...